Corrigendum: Defining a Radiomic Response Phenotype: A Pilot Study Using Targeted Therapy in NSCLC

Scientific Reports- United Kingdom

doi 10.1038/srep41197

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

P2.04-17 Pre-Therapy Radiomic Features Can Distinguish Hyperprogression From Other Response Patterns to PD1/PD-L1 Inhibitors in NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Defining a Unified Vascular Phenotype in Systemic Sclerosis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Targeted Alpha Therapy Using Astatine (211At)-Labeled Phenylalanine: A Preclinical Study in Glioma Bearing Mice

Oncotarget
Oncology
2020English

Quantitative Approach to Skin Field Cancerization Using a Nanoencapsulated Photodynamic Therapy Agent: A Pilot Study

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2013English

Response Distortion in Adolescents Who Smoke: A Pilot Study

Journal of Drug Education
Mental HealthEnvironmentalPublic HealthPsychiatryHealthMedicineOccupational Health
2002English

Pentoxifylline Therapy for Hepatopulmonary Syndrome: A Pilot Study

Archives of Internal Medicine
2008English

Pcn125 - First Insights Into Comparing Expenditures for Targeted Therapy and Survival in NSCLC

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

MRI in Predicting the Response of Gastrointestinal Stromal Tumor to Targeted Therapy: A Patient-Based Multi-Parameter Study

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy